MARKET

RHHBY

RHHBY

Roche Hldg
OTCQX
48.52
+0.33
+0.68%
Opening 15:07 12/05 EST
OPEN
48.74
PREV CLOSE
48.19
HIGH
48.76
LOW
48.15
VOLUME
411.20K
TURNOVER
19.92M
52 WEEK HIGH
49.19
52 WEEK LOW
33.01
MARKET CAP
--
P/E (TTM)
26.23
1D
5D
1M
3M
1Y
5Y
1D
FDA shift in drug study requirements sends trial runners lower
TipRanks · 1d ago
FDA to reduce number of trials required for drug approvals, STAT reports
TipRanks · 1d ago
OpenAI acquires startup Neptune to enhance training process: report
Seeking Alpha · 1d ago
Trevi Therapeutics: "Buy" Rating For Haduvio Treating Chronic Cough In IPF And Beyond
Seeking Alpha · 2d ago
REGN & Tessera Collaborate to Develop Gene-Editing Therapy for AATD
NASDAQ · 3d ago
Roche price target raised to CHF 290 from CHF 255 at Morgan Stanley
TipRanks · 3d ago
FDA top drugs official Pazdur retiring shortly after starting - report
Seeking Alpha · 3d ago
Roche price target raised to CHF 300 from CHF 290 at Berenberg
TipRanks · 3d ago
More
About RHHBY
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Webull offers Roche Holding AG (ADR) stock information, including OTCQX: RHHBY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RHHBY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RHHBY stock methods without spending real money on the virtual paper trading platform.